1.05
1.05 (0%)
As of Sep 30, 2024
Yield10 Bioscience, Inc. [YTEN]
Source:
Company Overview
Yield10 Bioscience, Inc. ("Yield10" or the "Company") is an agricultural bioscience company that is developing the oilseed Camelina sativa ("Camelina") as a platform crop for large scale production of low-carbon sustainable seed products to address:petroleum replacement markets, in which we are developing Camelina oil for use as a biofuel feedstock and PHA Bioplastics produced in Camelina seed for use as a biodegradable bioplastic; and food and nutrition markets, in which we are developing omega-3 (DHA EPA) oils produced in Camelina seed for aquaculture, nutraceuticals and protein meal for animal feed markets.
| Country | United States |
| Headquarters | woburn, massachusetts |
| Phone Number | 617-583-1700 |
| Industry | manufacturing |
| CEO | Oliver P. Peoples, Ph.D. |
| Website | yield10bio.com. |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0.5 |
| Operating Profit | $-3.2 |
| Net Income | $-3.2 |
| Net Cash | $-0.6 |
Profit Ratios
| Gross Margin | $0.5 |
| Operating Margin | -711.8 |
| Profit as % of Revenues | -13.9% |
| Profit as % of Assets | -189.5% |
| Profit as % of Stockholder Equity | 51.9% |
Management Effectiveness
| Return on Equity | 51.9% |
| Return on Assets | -109.1% |
| Turnover Ratio | 26.3% |
| EBITA | $-3.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $3 |
| Total Liabilities | $9.2 |
| Operating Cash Flow | $-1.5 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $0.9 |
